High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer

c-MET is considered a possible therapeutic target in numerous tumor types and is also a candidate regulator of response to anti-HER2 and anti-epidermal growth factor receptor (EGFR) therapy. The aim of this study was to determine the prevalence and clinical significance of c-MET expression in hormon...

Descripción completa

Detalles Bibliográficos
Autores principales: JACOBSEN, FRANK, ASHTIANI, SHARAD NOURAIE, TENNSTEDT, PIERRE, HEINZER, HANS, SIMON, RONALD, SAUTER, GUIDO, SIRMA, HÜSEYIN, TSOURLAKIS, MARIA CHRISTINA, MINNER, SARAH, SCHLOMM, THORSTEN, MICHL, UWE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524275/
https://www.ncbi.nlm.nih.gov/pubmed/23251249
http://dx.doi.org/10.3892/etm.2012.764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524275/
https://www.ncbi.nlm.nih.gov/pubmed/23251249
http://dx.doi.org/10.3892/etm.2012.764

Ejemplares similares